Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ADH1B | P00325 | 1/20 | 0.36 |
| ▸ | ADH1C | P00326 | 1/20 | 0.36 |
| ▸ | ADH1A | P07327 | 1/20 | 0.36 |
| ▸ | ADH4 | P08319 | 1/20 | 0.36 |
| ▸ | ADH7 | P40394 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.35 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.35 |
| ▸ | PRKCG | P05129 | 1/20 | 0.35 |
| ▸ | PRKCB | P05771 | 1/20 | 0.35 |
| ▸ | PRKCA | P17252 | 1/20 | 0.35 |
| ▸ | PRKCH | P24723 | 1/20 | 0.35 |
| ▸ | PRKCI | P41743 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31187930 | 1.00 | ACE2 (0.44) | ACE2OPRM1SPHK1LMNADNM1 | |
| SCHEMBL31181919 | 0.91 | ACE2 (0.41) | ACE2OPRM1SPHK1LMNADNM1 | |
| SCHEMBL10542838 | 0.91 | — | — | |
| SCHEMBL10540976 | 0.91 | — | — | |
| SCHEMBL10545418 | 0.91 | — | — | |
| SCHEMBL31187958 | 0.82 | ACE2 (0.48) | ACE2OPRM1SPHK1LMNADNM1 | |
| SCHEMBL17287347 | 0.81 | ACE2 (0.47) | ACE2OPRM1SPHK1LMNADNM1 | |
| SCHEMBL10543361 | 0.80 | — | — | |
| SCHEMBL10546329 | 0.80 | — | — | |
| SCHEMBL3117239 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2949641-B1 | METHOD FOR PRODUCING 3,5-DIMETHYLDODECANOIC ACID | SHINETSU CHEMICAL CO (JP) | 2017-10-04 | — | — | EP | disclosed |
| US-9278900-B2 | Method for producing 3,5-dimethyldodecanoic acid | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-03-08 | — | — | US | disclosed |
| US-20150344396-A1 | METHOD FOR PRODUCING 3,5-DIMETHYLDODECANOIC ACID | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2015-12-03 | — | — | US | disclosed |
| EP-2949641-A1 | METHOD FOR PRODUCING 3,5-DIMETHYLDODECANOIC ACID | Shin-Etsu Chemical Co., Ltd. (JP) | 2015-12-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150344396-A1 | METHOD FOR PRODUCING 3,5-DIMETHYLDODECANOIC ACID | MSMO1, MLYCD, ME3 | ACE2 1992/4885OPRM1 673/4885SPHK1 4204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.